GlassScriptPhysician profile
Justin M Markow
NPI 1336414168
$415.35
in general payments reported to CMS, 2019-2025
13 companies · $39.53 in 2025
The $39.53 reported for 2025 was less than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $11.92 · 2023: $143 · 2024: $221 · 2025: $39.53.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $318 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $318.44 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $106.43 | 2023 | Iclusig |
| Merck Sharp & Dohme LLC | $57.54 | 2024 | Keytruda, Lynparza |
| Lilly USA, LLC | $45.67 | 2024 | Retevmo, Jaypirca, Verzenio |
| Sobi, INC | $31.98 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $29.86 | 2024 | Imfinzi |
| Geron Corporation | $22.63 | 2025 | Rytelo |
| Novartis Pharmaceuticals Corporation | $22.36 | 2024 | |
| Genentech USA, INC. | $19.38 | 2024 | Lunsumio, Polivy |
| Janssen Biotech, INC. | $18.75 | 2023 | Erleada |
| Masimo Corporation | $17.34 | 2023 | Set and Rainbow Set, Patient Safetynet System |
| Abbvie INC. | $16.90 | 2025 | |
| Daiichi Sankyo INC. | $14.59 | 2024 | Injectafer |
| Gilead Sciences, INC. | $11.92 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justin Markow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.